YAFO Capital

Founded in 2013, YAFO Capital is a Shanghai-based boutique investment & advisory firm focusing on healthcare and technology investment. YAFO, Hebrew meaning of beautiful, started from bringing Israeli technologies to China, now with offices in the US, Japan, and Europe.

YAFO Life Science – The gateway for global biopharma & medtech to China.

YAFO Life Science

YAFO Life Science is the investment banking division of YAFO Capital with a focus on global biopharma and medtech licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Japan. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China, aiming at bridging the gap between global medical technologies and the Chinese market. We also represent leading Chinese biotech companies to explore licensing/partnership opportunities globally.
View Life Science


YAFO Life Science is a founding partner of BioToChina.org, a platform dedicated to bringing leading innovative biotech companies to China.
The platform matches the financing or strategic demands of innovative biotech companies, qualified institutional investors, and specialized service providers.
View BioToChina.org

Navigating your entry into China markets and access to local resources and funding.

Fund Management

YAFO Healthcare Fund actively searching for innovative companies within all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health, partnering with those that have strong growth potential in China market. Our mission is to bridge the gap between undercapitalized life science projects, companies, and investors through direct investment and/or licensing/co-development arrangements.

View Fund Management

We are proud of what we are doing as the technologies we introduce to China improve our living and environment

Our Team Members

Our expertise allows YAFO Capital to deliver added value throughout all aspects of a transaction – opportunity identification, strategy development, deal planning, execution, negotiations, structuring, and closing.

Sean Jiang, CFA

Founder & CEO
20 years of Wall Street experience, banking & investment of technologies

Kun Tao, CFA

Partner, Head of U.S. Business
20+ years of Wall Street experience in equity research and cross-border pharma licensing/investment

Fan Zheng

Managing Director
Extensive involvement and expertise in 30+ global life science licensing & cross border financial transactions

William Yao

30 years+ healthcare experience, including 7+ years in AstraZeneca China

Xin Fang, Ph.D

Investment Manager
Analyst at Roche R&D AP and Nielsen Analytics before join Yafo

Events & News

View More